Aptose Biosciences Inc (NAS:APTO)
$ 0.1821 0.0031 (1.73%) Market Cap: 10.62 Mil Enterprise Value: 3.11 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Q4 2023 Aptose Biosciences Inc Earnings Call Transcript

Mar 26, 2024 / 09:00PM GMT
Release Date Price: $1.6 (+5.96%)
Operator

Good afternoon. My name is Jonathan, and I will be your conference operator today. I would like to welcome everyone to Aptose Biosciences conference call for the fourth quarter and year ended December 31, 2023. (Operator Instructions) As a reminder, this conference call may be recorded. And now I'd like to introduce to your host for today's program Susan Pietropaolo. Please go ahead.

Susan Pietropaolo
Aptose Biosciences Inc. - IR

Thank you, Jonathan. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the fourth quarter and year ended December 31, 2023. Earlier today, Aptose issued a press release relating to the financial results. The news release as well as related SEC filings are accessible on Aptose's website.

Joining me on today's call are Dr. William Rice, Chairman, President, and CEO; Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer; and Mr. Fletcher Payne, Senior Vice President, Chief Financial Officer and Chief Business Officer.

Before we proceed, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot